S L Orton

Summary

Affiliation: American Red Cross
Country: USA

Publications

  1. ncbi Validation of selected donor-screening questions: structure, content, and comprehension
    S L Orton
    Jerome Holland Laboratory, American Red Cross, Rockville, Maryland, USA
    Transfusion 40:1407-13. 2000
  2. ncbi Prevalence of circulating Treponema pallidum DNA and RNA in blood donors with confirmed-positive syphilis tests
    Sharyn L Orton
    American Red Cross Holland Laboratory, Rockville, Maryland, USA
    Transfusion 42:94-9. 2002
  3. ncbi Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening
    J Aberle-Grasse
    Holland Laboratory, American Red Cross Blood Services, Rockville, Maryland 20855, USA
    Transfusion 39:206-11. 1999
  4. ncbi Absence of risk factors for false-positive test results in blood donors with a reactive test result in an automated treponemal test (PK-TP) for syphilis
    S L Orton
    American Red Cross Holland Laboratory, Rockville, Maryland, USA
    Transfusion 41:744-50. 2001
  5. ncbi Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L
    E P Notari
    Jerome H Holland Laboratory, American Red Cross, Rockville, Maryland, USA
    Transfusion 41:751-5. 2001
  6. ncbi Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors
    S L Orton
    Division of Blood Applications, FDA, CBER, OBRR, Rockville, Maryland, USA
    Transfusion 46:272-7. 2006
  7. ncbi Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV
    S L Orton
    American Red Cross, Gaithersburg and Rockville, Maryland, USA
    Transfusion 44:275-81. 2004
  8. ncbi Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11, 2001
    Roger Y Dodd
    Transfusion 42:1240-1. 2002

Collaborators

Detail Information

Publications8

  1. ncbi Validation of selected donor-screening questions: structure, content, and comprehension
    S L Orton
    Jerome Holland Laboratory, American Red Cross, Rockville, Maryland, USA
    Transfusion 40:1407-13. 2000
    ..Questions are frequently added to this screening procedure, but they are rarely evaluated for comprehension...
  2. ncbi Prevalence of circulating Treponema pallidum DNA and RNA in blood donors with confirmed-positive syphilis tests
    Sharyn L Orton
    American Red Cross Holland Laboratory, Rockville, Maryland, USA
    Transfusion 42:94-9. 2002
    ..DNA PCR and RNA RT-PCR were applied to assess the presence of Treponema pallidum DNA or RNA in blood donors with confirmed-positive results in STS...
  3. ncbi Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening
    J Aberle-Grasse
    Holland Laboratory, American Red Cross Blood Services, Rockville, Maryland 20855, USA
    Transfusion 39:206-11. 1999
    ..This study evaluated the change from a rapid plasma reagin (RPR) test to an automated specific treponemal test (PK-TP) in screening for syphilis in blood donors...
  4. ncbi Absence of risk factors for false-positive test results in blood donors with a reactive test result in an automated treponemal test (PK-TP) for syphilis
    S L Orton
    American Red Cross Holland Laboratory, Rockville, Maryland, USA
    Transfusion 41:744-50. 2001
    ....
  5. ncbi Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L
    E P Notari
    Jerome H Holland Laboratory, American Red Cross, Rockville, Maryland, USA
    Transfusion 41:751-5. 2001
    ..ALT testing of blood donors was initiated as a surrogate marker for non-A, non-B hepatitis. Increased sensitivity of subsequent HBV and HCV tests used for standard donor screening make any residual value of ALT testing questionable...
  6. ncbi Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors
    S L Orton
    Division of Blood Applications, FDA, CBER, OBRR, Rockville, Maryland, USA
    Transfusion 46:272-7. 2006
    ..This study suggests that asking donors about predonation headache and fever had no detectable contribution to blood safety...
  7. ncbi Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV
    S L Orton
    American Red Cross, Gaithersburg and Rockville, Maryland, USA
    Transfusion 44:275-81. 2004
    ..Of over 26.8 million donations tested between March 3, 1999, and March 31, 2003, 810 were HCV-reactive by NAT. A subset of these donors was assessed for recent exposure risk...
  8. ncbi Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11, 2001
    Roger Y Dodd
    Transfusion 42:1240-1. 2002